Atria Wealth Solutions’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Atria Wealth Solutions’s Portfolio IEIH Stock Details IEIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,945	Closed	-$426K	–	1890
2022 Q2	$426K	Sell	12,945 -2,026	-14%	-$66.5K	0.01%	1052
2022 Q1	$513K	Buy	+14,971	New	+$495K	0.01%	1056

Atria Wealth Solutions's IEIH Position: Q3 2022 in Review

Atria Wealth Solutions sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 12,945 shares — an estimated $426K sold.

Atria Wealth Solutions first reported a position in IEIH in Q1 2022 and held it in 2 quarters. The position peaked at $513K in Q1 2022. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

Atria Wealth Solutions reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
Atria Wealth Solutions sold 12,945 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $426K.
Atria Wealth Solutions first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q1 2022 and held it in 2 quarters.
Atria Wealth Solutions's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $513K in Q1 2022.
0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on Atria Wealth Solutions's 13F filing for Q3 2022, filed 14 Nov 2022.